• Profile
Close

Coronavirus vaccine will be equally effective against new mutant of coronavirus: CSIR DG

PTI Dec 22, 2020

The coronavirus vaccines will be equally effective against the new mutant of the virus and there is no reason to panic, the Council for Scientific and Industrial Research Director General said on 21 December.

For our comprehensive coverage and latest updates on COVID-19 click here.


He said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it is more lethal and more people are going to die due to it. "It is likely that there will be differences between certain aspects like anti-bodies but it doesn't necessarily mean that vaccines will be ineffective. Vaccines will be equally effective despite the mutation. So there is no reason to panic," the Council for Scientific and Industrial Research Director General told PTI.

Indian institutions have sequenced over 4,000 genomes of the coronavirus and submitted to the Global Initiative on Sharing All Influenza Data (GISAID). The CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi and Centre for Cellular and Molecular Biology (CCMB), Hyderabad have alone done sequencing of over 2,200 genome sequences of coronavirus in India. The Council for Scientific and Industrial Research Director General said, "We have not found this (particular mutation) in Indian isolates yet." He said scientists in India and all over the world are watching this variant closely.

The mutation has been independently observed in the UK, Brazil and South Africa, he said. "Scientists are looking at the mutations very closely. It is too early to draw any conclusions," the Council for Scientific and Industrial Research Director General said. He said the new variant can be diagnosed with the RT-PCR but it needs to be assessed if it can be equally effective for the Rapid Antigen tests. "But there is nothing to suggest it (RAT) does not work right now," he said. The Council for Scientific and Industrial Research Director General said there might be differences in the monoclonal (lab-made) antibodies which recognise the particular region in a virus which is not otherwise mutated. "But in the mutated virus that monoclonal antibody may not effectively work against this changed variant," he added.

Several European countries -- France, Germany, the Netherlands, Belgium, Austria and Italy -- have banned flights from the UK with the British government warning that the potent new strain of the virus was "out of control" and imposing a stringent new stay-at-home lockdown from 20 December. The British Prime Minister last week said a fast-moving new variant of the virus that is 70 percent more transmissible than existing strains appeared to be driving the rapid spread of new infections in London and southern England in recent weeks. But he stressed "there's no evidence to suggest it is more lethal or causes more severe illness," or that vaccines will be less effective against it.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay